Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05630859 |
|---|---|
| Brief Title: | Safety and Efficacy of GSK Neisseria Gonorrhoeae GMMA (NgG) Investigational Vaccine When Administered to Healthy Adults 18 to 50 Years of Age. |
| First Submitted : | November 25, 2022 |
| First Submitted that Met QC Criteria : | November 25, 2022 |
| First Posted : | November 30, 2022 |
| Last Update Submitted that Met QC Criteria : | April 19, 2024 |
| Last Update Posted : | April 22, 2024 |